Not provided
Not provided
Not provided
Not provided
Slow recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the Lutonix® 035 Drug Coated Balloon PTA Catheter (CE mark) for use as intended in the treatment of subjects with clinically significant hemodialysis vascular access stenosis or occlusion.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Lutonix Paclitaxel Drug Coated Balloon | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lutonix Paclitaxel Drug Coated Balloon | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Efficacy: Primary Patency | Target Lesion Primary Patency (TLPP): The interval following index procedure intervention until the next reintervention of the target lesion or access thrombosis. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Target Lesion Primary Patency (TLPP) | 12 months | |
| Access circuit primary patency | 6 and 12 months | |
| Abandonment of permanent access in the index extremity |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| LKH-Univ. Klinikum Graz | Graz | 8036 | Austria | |||
| Klinikum Klagenfurt am Wörthersee |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 and 12 months |
| Number of interventions required to maintain target lesion patency | 6 and 12 months |
| Number of interventions, required to maintain access circuit patency | The access circuit is defined as "the area from the AV access graft arterial anastomosis to the superior vena-cava right atrial junction." The outcome is recording all interventions that occur in the access circuit up until the time of circuit failure (patency). | 6 and 12 months |
| Major vascular complications | < or at 1 month |
| Rate of device and procedure related adverse events | 1, 6 and 12 months |
| Klagenfurt |
| 9020 |
| Austria |
| Universitätsklinikum Köln AöR | Cologne | 50937 | Germany |
| Universitätsklinikum Schleswig-Holstein - Campus Lübeck | Lübeck | 23538 | Germany |